Crysvita, a product of Ultragenyx Pharmaceutical, received breakthrough therapy designation for its drug GTX-102, while also generating revenue in Turkey and Europe.

The entities involved

• Ultragenyx Pharmaceutical →

  biopharmaceutical company based in Novato, California, United States

  Nothing else this week.

• Turkey →

  country in West Asia and Southeast Europe

  • Settlers migrated from Syria and Turkey to Crete on September 24, 2026.Mon 17:25
  • Turkey participates in a NATO summit and seeks to repair ties with the Trump administration.Mon 15:49
• Europe →

  terrestrial continent located in north-western Eurasia

  • The European Commission aims to strengthen homegrown AI capabilities while global advanced models face usage restrictions.Mon 17:49
  • The European Central Bank is forced to raise interest rates due to energy price shocks from the Iran war and an influx of Chinese exports.Mon 17:49
• FDA →
  • Generic medicine services are seeking approval for launch from the FDA.Mon 17:49
  • A company is seeking FDA feedback on its NEO212 program, with a meeting scheduled at the FDA's White Oak campus.Mon 14:56